Category: Federal

Health Center Leaders Urge Boards to Push State, Federal Support of 340B

August 29, 2023 Rich Daly, Editor in Chief Views

The National Association of Community Health Centers’ CHI and Expo addressed the advocacy role of health center boards of directors.

The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

August 24, 2023 Rich Daly, Editor in Chief Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Activity Experiences Historic Surge

August 15, 2023 Rich Daly, Editor in Chief Views

Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.

The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Let For-Profit Hospitals Into 340B, Trade Association Tells Senators

August 10, 2023 Tom Mirga, Editor at Large Views

The Federation of American Hospitals has asked six U.S. senators to let for-profit hospitals join the 340B program.

Congress should let for-profit hospitals into the 340B drug pricing program as “a long overdue evolutionary step” that will advance [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Government Watchdog Reissues Controversial Finding on Adverse Incentives in 340B Program

August 8, 2023 William Newton, Associate Editor/Senior Writer Views

GAO restated its controversial 2015 finding that 340B covered entities prescribe more drugs or more expensive drugs than necessary.

The U.S. Government Accountability Office late last month restated its controversial recommendation that Congress take actions to reduce incentives for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bipartisan AG Group Urges Senate to Protect 340B Contract Pharmacy Agreements, Require Provider Transparency

August 3, 2023 Rich Daly, Editor in Chief Views

Connecticut Attorney General William Tong (D) led a bipartisan group of state attorneys general urging changes to the 340B program.

Twenty-three state attorneys general urged a group of U.S. senators crafting a legislative overhaul of the 340B program to add [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

On Deadline Day for Senate Feedback, Researchers in JAMA Urge 340B Provider Reporting, Tightening Eligibility, Preventing Drug Overcharges

August 3, 2023 Rich Daly, Editor in Chief Views

On the day a group of bipartisan Senators requested feedback from stakeholders, an influential academic and his colleagues published a series of recommendations to reform the 340B program in JAMA

A high-profile researcher and colleagues are urging a range of changes to the 340B program, including new provisions on transparency, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Claims Clearinghouse, Strengthening HRSA Among Few Consensus Areas in Responses to Senate 340B Overhaul Effort

August 1, 2023 Rich Daly, Editor in Chief Views

Sen. John Thune is part of a bipartisan group of six senators that solicited stakeholder advice on strategies to reform the 340B program.

The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Broad Support Emerges for Adding Duplicate Discount Modifiers to Medicaid Cards

August 1, 2023 Rich Daly, Editor in Chief Views

340B stakeholders broadly support adding identifiers to Medicaid drug beneficiaries’ cards to held avoid duplicate 340B discounts, comments on a CMS proposed rule show.

A federal proposal to require the addition of new identifiers to Medicaid drug beneficiaries’ cards to avoid duplicate 340B discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

July 27, 2023 William Newton, Associate Editor/Senior Writer Views

Senate Finance Committee PBM reform bill markup.

The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.

The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live